Takaoka, Japan

Kyoko Kasuya

This inventor holds 1 USPTO granted patent. Top assignee: Toyama Chemical Co., Ltd.. Active years: 1976.


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1976

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kyoko Kasuya: Innovator in Antibacterial Compounds

Introduction

Kyoko Kasuya is a notable inventor based in Takaoka, Japan. She has made significant contributions to the field of medicinal chemistry, particularly in the development of novel antibacterial compounds. Her work focuses on enhancing the efficacy of antibiotics, which is crucial in the fight against bacterial infections.

Latest Patents

Kasuya holds a patent for "Bis-type penicillins and process for producing the same." This patent describes novel bis-type penicillins that contain a (thio)acylureido group in their molecular structure. These compounds are valuable antibacterial agents for use in mammals, including humans. The patent outlines a process for the preparation of these compounds, highlighting their potential in medical applications.

Career Highlights

Kasuya is associated with Toyama Chemical Co., Ltd., where she has been instrumental in advancing research in antibacterial agents. Her innovative approach and dedication to her work have positioned her as a key figure in her field. With a total of 1 patent, she continues to contribute to the scientific community.

Collaborations

Kasuya collaborates with esteemed colleagues, including Seietsu Kuroda and Miwako Komatsu. These partnerships enhance the research and development efforts at Toyama Chemical Co., Ltd., fostering an environment of innovation and discovery.

Conclusion

Kyoko Kasuya's contributions to the field of antibacterial compounds exemplify her commitment to improving healthcare through innovation. Her work not only advances scientific knowledge but also has the potential to impact the treatment of bacterial infections significantly.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…